World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Slovenia
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
17012
World Ranking
5139
National Ranking
3

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • 2025 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • 2023 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • 2022 - Research.com Biology and Biochemistry in Slovenia Leader Award
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Janko Kos is affiliated with the University of Ljubljana in Slovenia and has a significant research output in fields primarily related to medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their main research areas include molecular biology, immunology, oncology, cancer research, and physiology.

The scientist's work covers several key research topics such as protease and inhibitor mechanisms, peptidase inhibition and analysis, immune cell function and interaction, immune cells in cancer, neuroscience and neuropharmacology research, cell adhesion molecules research, and cholinesterase and neurodegenerative diseases.

Frequent co-authors collaborating with Janko Kos include Anja Pišlar, Ana Mitrović, Stanislav Gobec, Emanuela Senjor, and Milica Perišić Nanut.

Janko Kos has published numerous papers, some of the recent notable ones are:

  • The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors, 2020, PLoS Pathogens
  • Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discovery, 2022, Biomedicine & Pharmacotherapy
  • N-alkylpiperidine carbamates as potential anti-Alzheimer's agents, 2020, European Journal of Medicinal Chemistry
  • Stereoselective Activity of 1-Propargyl-4-styrylpiperidine-like Analogues That Can Discriminate between Monoamine Oxidase Isoforms A and B, 2020, Journal of Medicinal Chemistry
  • Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity, 2020, European Journal of Medicinal Chemistry

The frequent publication venues for their research include:

  • International Journal of Molecular Sciences
  • Frontiers in Immunology
  • European Journal of Medicinal Chemistry
  • The Cambridge Structural Database
  • Cellular and Molecular Life Sciences

Janko Kos has also contributed to academic literature through book publications. Publishers include Založba Univerze v Ljubljani (University of Ljubljana Press) eBooks and Znanstvena založba Filozofske fakultete Univerze v Ljubljani (Ljubljana University Press, Faculty of Arts) eBooks.

  • Spomin jezika, jezik spomina: študije o pesniškem jeziku, 2022
  • Janko Kos in slovenska primerjalna književnost, 2023
  • Trojka s filozofske: spisi o Vebru, Bartolu in Jugu, 2020

The scientist has been recognized as a member of the European Academy of Sciences and Arts.

Best Publications

  • The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.

    W. Bode;R. Engh;D. Musil;U. Thiele

  • Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.

    Petra Kocbek;Nataša Obermajer;Mateja Cegnar;Janko Kos

  • Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).

    J Kos;T T Lah

  • Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.

    Boris Brus;Urban Košak;Samo Turk;Anja Pišlar

  • Cysteine Proteinase Inhibitors Stefin A, Stefin B, and Cystatin C in Sera from Patients with Colorectal Cancer: Relation to Prognosis

    Janko Kos;Marta Krašovec;Nina Cimerman;Hans Jørgen Nielsen

  • Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer.

    Vito Turk;Boris Turk;Gregor Gunčar;Dušan Turk

  • Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.

    J Kos;B Stabuc;A Schweiger;M Krasovec

  • Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients.

    Nina Cimerman;Pika Meško Brguljan;Marta Krašovec;Stanislav Šuškovič

  • Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer.

    J Kos;B Werle;T Lah;N Brunner

  • Cystatins in Immune System

    Špela Magister;Janko Kos

  • Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor.

    Werner Machleidt;Werner Machleidt;Ulrich Thiele;Ulrich Thiele;Bernd Laber;Bernd Laber;Irmgard Assfalg-Machleidt;Irmgard Assfalg-Machleidt

  • Serum Cystatin C, a New Marker of Glomerular Filtration Rate, Is Increased during Malignant Progression

    Janko Kos;Borut S̆tabuc;Nina Cimerman;Nils Brünner

  • Proteins of higher fungi – from forest to application

    Jana Erjavec;Janko Kos;Maja Ravnikar;Tanja Dreo

  • Cysteine cathepsins (proteases)—On the main stage of cancer?

    Vito Turk;Janko Kos;Boris Turk

  • Microbial and fungal protease inhibitors—current and potential applications

    Jerica Sabotič;Janko Kos

  • Prognostic significance of cathepsins B and L in primary human breast cancer.

    J. A. Foekens;J. Kos;H. A. Peters;M. Krasovec

  • Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.

    Aleš Premzl;Valentina Zavašnik-Bergant;Vito Turk;Janko Kos

  • Cysteine proteinases in cancer progression and their clinical relevance for prognosis.

    T T Lah;J Kos

  • Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins.

    Boris Turk;Joseph G. Bieth;Ingemar Björk;Iztok Dolenc

  • Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.

    Strojnik T;Kos J;Zidanik B;Golouh R

Frequent Co-Authors

Stanislav Gobec
Stanislav Gobec University of Ljubljana
Vito Turk
Vito Turk Jožef Stefan Institute
Tamara T. Lah
Tamara T. Lah National Institute of Biology
Dušan Turk
Dušan Turk Jožef Stefan Institute
Anahid Jewett
Anahid Jewett University of California, Los Angeles
Boris Turk
Boris Turk Jožef Stefan Institute
Borut Štrukelj
Borut Štrukelj University of Ljubljana
Florian Nachon
Florian Nachon Centre national de la recherche scientifique, CNRS
Nils Brünner
Nils Brünner University of Copenhagen
Wolfram Bode
Wolfram Bode Max Planck Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Janko Kos

Trending Scientists

Recently Published Articles